Literature DB >> 23128330

Young age at diagnosis, male sex, and decreased lean mass are risk factors of osteoporosis in long-term survivors of osteosarcoma.

Jung Sub Lim1, Dong Hwan Kim, Jun Ah Lee, Dong Ho Kim, Joongbum Cho, Wan Hyeong Cho, Soo-Yong Lee, Dae-Geun Jeon.   

Abstract

BACKGROUND: Long-term survival of children with osteosarcoma has increased, but most suffer from osteoporosis in adulthood. The aim of this study was to investigate the prevalence and identify the risk factors of osteoporosis.
METHODS: Forty long-term survivors of osteosarcoma and 55 controls were enrolled. The mean age of the survivors was 21.8 ± 5.2 years. They were diagnosed at younger than 23 years of age (mean, 14.9 + 5.0 y). Bone mineral densities (BMD) and body compositions were measured by dual-energy x-ray absorptiometry.
RESULTS: Nineteen (47.5%) subjects had osteoporosis and 12 (30.0%) had osteopenia. The regions affected by osteoporosis were: femur neck of osteosarcoma site (47.5%), unaffected femur neck (12.5%), lumbar spine (12.5%), and total body (15.0%). Twelve subjects (30.0%) had 14 episodes of fractures. The identified risk factors of osteoporosis were young age at diagnosis, male sex, and low lean mass. Subjects diagnosed before attainment of puberty (male ≤ 16 y, female ≤ 14 y) were found to have a higher prevalence of osteoporosis (37.5% vs. 10.0%, P < 0.01). Males had a higher prevalence of osteopenia or osteoporosis than females (86.4% vs. 66.7%, P < 0.01). Total lean mass was positively correlated with unaffected femur neck BMD. Regional lean mass in affected limb was significantly reduced along with affected femur neck BMD.
CONCLUSIONS: In long-term survivors of osteosarcoma, prevalence of osteoporosis and fracture was higher than expected. Initial evaluation and regular follow-up of BMD should be performed in all osteosarcoma patients, especially in those who did not attain puberty, males, and those with a low lean mass.

Entities:  

Mesh:

Year:  2013        PMID: 23128330     DOI: 10.1097/MPH.0b013e318275193b

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  13 in total

1.  Reference values for bone mineral density according to age with body size adjustment in Korean children and adolescents.

Authors:  Kyung Hee Yi; Jin Soon Hwang; Eun Young Kim; Jun Ah Lee; Dong Ho Kim; Jung Sub Lim
Journal:  J Bone Miner Metab       Date:  2013-07-06       Impact factor: 2.626

2.  Identifications of genetic differences between metastatic and non-metastatic osteosarcoma samples based on bioinformatics analysis.

Authors:  Baoyong Sun; Fangxin Wang; Min Li; Mingshan Yang
Journal:  Med Oncol       Date:  2015-04-02       Impact factor: 3.064

3.  Bone mineral density change during adjuvant chemotherapy in pediatric osteosarcoma.

Authors:  Ju Hyun Ahn; Wan Hyeong Cho; Jun Ah Lee; Dong Ho Kim; Ju-Hee Seo; Jung Sub Lim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-09-30

4.  Sclerostin expression in skeletal sarcomas.

Authors:  Jia Shen; Carolyn A Meyers; Swati Shrestha; Arun Singh; Greg LaChaud; Vi Nguyen; Greg Asatrian; Noah Federman; Nicholas Bernthal; Fritz C Eilber; Sarah M Dry; Kang Ting; Chia Soo; Aaron W James
Journal:  Hum Pathol       Date:  2016-08-03       Impact factor: 3.466

5.  Screening for vitamin D insufficiency in pediatric cancer survivors.

Authors:  Adam J Esbenshade; Jenna Sopfe; Zhiguo Zhao; Zeda Li; Kristin Campbell; Jill H Simmons; Debra L Friedman
Journal:  Pediatr Blood Cancer       Date:  2013-11-05       Impact factor: 3.167

6.  Bone mineral density after childhood cancer in 346 long-term adult survivors of childhood cancer.

Authors:  M A H den Hoed; B C Klap; M L te Winkel; R Pieters; M van Waas; S J C M M Neggers; A M Boot; K Blijdorp; W van Dorp; S M F Pluijm; M M van den Heuvel-Eibrink
Journal:  Osteoporos Int       Date:  2014-09-11       Impact factor: 4.507

7.  CORR Insights®: Is There an Association Between Bone Microarchitecture and Fracture in Patients who were Treated for High-grade Osteosarcoma? A Controlled Study at Long-term Follow-up Using High-resolution Peripheral Quantitative CT.

Authors:  Andre Mathias Baptista
Journal:  Clin Orthop Relat Res       Date:  2021-11-01       Impact factor: 4.755

8.  Prediction of Low and Very Low Bone Mineral Density Among Adult Survivors of Childhood Cancer.

Authors:  Jenneke E van Atteveld; Saskia M F Pluijm; Kirsten K Ness; Melissa M Hudson; Wassim Chemaitilly; Sue C Kaste; Leslie L Robison; Sebastian J C M M Neggers; Yutaka Yasui; Marry M van den Heuvel-Eibrink; Carmen L Wilson
Journal:  J Clin Oncol       Date:  2019-05-31       Impact factor: 50.717

9.  Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density.

Authors:  Se Won Lim; Ju Hyun Ahn; Aery Choi; Wan Hyeong Cho; Jun Ah Lee; Dong Ho Kim; Ju-Hee Seo; Jung Sub Lim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-03-31

10.  Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human osteosarcoma.

Authors:  Francesca Punzo; Chiara Tortora; Daniela Di Pinto; Iolanda Manzo; Giulia Bellini; Fiorina Casale; Francesca Rossi
Journal:  Oncotarget       Date:  2017-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.